C5AR1 and infection: Most importantly, we could demonstrate that interference with complement-derived inflammation caused by pharmacological blockade of C5aR1 ameliorates inflammatory cytokine release in human whole-blood infection and leads to increased survival in experimental N. meningitidis sepsis.